Sands Capital Ventures »

Klaviyo Srs A Ord shares owned by Sands Capital Ventures

Quarter-by-quarter ownership of Klaviyo Srs A Ord (KVYO) shares owned by Sands Capital Ventures from 13F filings

Historical chart of Sands Capital Ventures investment in Klaviyo Srs A Ord

Tip: Access up to 7 years of quarterly data

All positions including Klaviyo Srs A Ord held by Sands Capital Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Klaviyo Srs A Ord by Sands Capital Ventures

Quarter filed Position value Share count Share price at filing
2023-09-30 $16M 469k 34.50

More positions owned by Sands Capital Ventures

Nu Hldgs Ord Shs Cl A (NU)
Uipath Cl A (PATH)
Doordash Cl A (DASH)
Snowflake Cl A (SNOW)
Rayzebio
Samsara Com Cl A (IOT)
10x Genomics Cl A Com (TXG)
Klaviyo Class A Com (KVYO)
Acrivon Therapeutics Common Stock (ACRV)
Acumen Pharmaceuticals (ABOS)
Olink Hldg Ab Sponsored Ads (OLK)
Tarsus Pharmaceuticals (TARS)
Taysha Gene Therapies Com Shs (TSHA)
Spruce Biosciences (SPRB)
908 Devices (MASS)

View all positions for Sands Capital Ventures

Top funds holding Klaviyo Srs A Ord

Summit Partners
ClearBridge Advisors
Vanguard Group
Alliancebernstein
Jpmorgan Chase & Co
Goldman Sachs Group
Franklin Resources
Blue Owl Capital Holdings
Claro Advisors
Norges Bank Investment Management
Federated Investors
Bank of New York Mellon
Millennium Management
Glynn Capital Management
Whale Rock Capital Management

View all funds holding Klaviyo Srs A Ord